Healthcare Innovations Expo is a perfect platform for Synexus
Michael Fort, Synexus CEO is looking forward to the opportunity to explain the success his company is achieving in the clinical trials sector: "We are very keen to drive up the UK's participation in global clinical trials and are already helping make this happen through our close work with PCTs and GPs, but much more needs to be done. Over the past few years overall UK involvement in global clinical trials has declined whilst at Synexus we have managed to increase patient visits by 50% in 2008 alone. We are happy to work more closely with the Department of Health on re-gaining the UK's position as a leader in clinical trials. Our clinical trials model, which is really changing the way trials are done is an example of innovation which could be expanded."
Synexus works with pharma, biotechs and CROs and has a network of wholly owned and dedicated clinical trial sites in the UK, Central and Eastern Europe as well as in India and South Africa. The company currently has more than 14,000 patients enrolled onto clinical trials programmes across a range of therapeutic areas.
For more information please go to: www.synexus.com
Have more questions? Contact us for more information
